About Us

Zurex Pharma, Inc. is a specialty pharma and medical technology company with a novel antimicrobial technology platform. Our company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent Health Care-Associated Infections with a focus on surgical site wounds and catheter-related infections.

At Zurex Pharma, we have assembled a team of experienced professionals with a solid track record of product development and commercialization.


  • Paul Vajgrt, CEO
  • R. Andrew Morgan, Executive Vice President, Regulatory Affairs and Quality Operations
  • Alex M. Kasper, Chief Financial Officer

Corporate Partners

  • AlphaTech Counsel, General Legal Counsel
  • Baker Tilly Virchow Krause, LLP, Accounting and Tax Consulting
  • Casimir Jones, S.C., Intellectual Property
  • Leydig, Voit & Mayer, Intellectual Property
  • Makin' Hey, Marketing Communications
  • Latham & Watkins LLP, Strategic Counsel
  • Perella Weinberg Partners, Strategic Advisors


  • Frederick A. Robertson, M.D., Chairman
  • Thomas V. Ressemann, Independent Director
  • Michael Liang, Ph.D., Partner, Baird Capital
  • Robert B. Truitt, President and CEO, Ash Access Technology




Zurex Pharma's corporate office is located in the Middleton Industrial Park. Specific comments or questions may be submitted online through our contact page.


Presurgical skin preparation
for the prevention of surgical
site infections.

Patient Bathing

Novel, highly effective, anti-septic patient bathing and hand hygiene products are in the works.

Wound Care

Post-surgical solutions for the prevention of surgical site infections and wound management.


Prevention of intra-luminal catheter-related bloodstream infections in central line catheters.

Zurex Product Line

Our goal is to provide safe and effective anti-microbial products designed to reduce the risks associated with health care-associated infections with a focus on surgical site wounds and catheter-related bloodstream infections (CRBSI).